Skip to main content
Log in

Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves’ Orbitopathy?

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Graves’ disease (GD) is an autoimmune disorder affecting primarily the thyroid gland. The most common extrathyroidal manifestation of GD is known as Graves’ orbitopathy (GO). Bone marrow-derived fibrocytes represent a subset of monocytes in peripheral blood mononuclear cells (PBMCs), infiltrate the orbital tissues, and contribute to the pathogenesis of GO. Hence objectives of the study included whether the concentration of fibrocytes in peripheral blood was higher in GO, whether TSHR m RNA expression and TSHR surface expression in peripheral blood were higher in GO in comparison to Graves’ Disease (GD) and Control subjects.

Methods

The percentage of circulating fibrocytes (FC) along with TSHR on its cell surface (CD 34+, CD 45+, CXCR4+, Collagen 1+, TSHR+) were assessed by flow cytometry of 50 patients with GD and GO and 15 healthy donors (Control). TSHR mRNA expression was measured by q RT PCR.

Result

The concentration of circulating fibrocytes was significantly higher in GO compared to GD and control [GO 17% vs GD 3% vs control 0.7% (p < 0.05)]. Moreover, these fibrocytes express a significantly higher level of TSHR in GO. This was corroborated by the measure of TSH mRNA; in GD it was 2.3-fold higher and in GO it was 3.9 fold higher than in control, in GO this transcript level was 1.7fold higher than GD (p < 0.05). TSHR+ fibrocytes were significantly positively correlated with CAS (p = 0.004) and negatively correlated with age (p = 0.01) and duration of disease (p = 0.01) in GO.

Conclusion

This study sheds further light on the pathogenesis of GO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

GO:

Graves’ Orbitopathy

TSHR:

Thyroid Stimulating Hormone Receptor

GD:

Graves’ Disease

PBMC:

Peripheral Blood mononuclear cells

FC:

Fibrocytes

CAS:

Clinical Activity Score

mRNA:

Messenger Ribonucleic Acid

EUGOGO:

European Group of Graves’ Orbitopathy

MRI:

Magnetic resonance imaging

CLIA:

Chemiluminescence Immune Assay

ECLIA:

Electrochemiluminescence Immune Assay

TRAb:

Thyroid Stimulating Hormone Receptor Antibody

qRT-PCR:

quantitative Real Time Polymerase Chain Reaction

GAPDH:

glyceraldehyde-3-phosphate dehydrogenase

CI:

Confidence Interval.

References

  1. E. Macchia, G.F. Fenzi, F. Monzani, L. Bartalena, F. Lippi, V. Aloisio, C. Cupini, L. Baschieri, A. Pinchera, TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease. J. Endocrinol. Invest 6, 375–378 (1983). https://doi.org/10.1007/BF03347619

    Article  CAS  PubMed  Google Scholar 

  2. R.S. Douglas, N.F. Afifiyan, C.J. Hwang, K. Chong, U. Haider, P. Richards, A.G. Gianoukakis, T.J. Smith, Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 95(1), 430–438 (2010). https://doi.org/10.1210/jc.2009-1614. January

    Article  CAS  PubMed  Google Scholar 

  3. T.J. Smith, A. Dolly, P. Claudio, L.U. Ying, N. Raychaudhuri, R. Fernando, S. Atkins, F. Erin, A.G.G. Gianoukakis, B.S. Miller, P.G. Gauger, G.M. Doherty, R.S. Douglas, Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves’ disease. J. Clin. Endocrinol. Metab. 96(12), 3827–3837 (2011). https://doi.org/10.1210/jc.2011-1249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Y.S. Hussain, J.C. Hookham, A. Allahabadia, S.P. Balasubramanian, Epidemiology, management and outcomes of Graves’ disease—real lifedata. Endocrine 56, 568–578 (2017). https://doi.org/10.1007/s12020-017-1306-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. P.M. Sudeep, P. Petros, Epidemiology of Graves’ orbitopathy. Pediatr. Endocrinol. Rev. 7(Suppl 2), 182–185 (2010). PMID: 20467360

    Google Scholar 

  6. M. Basak, N. Agrawal, S. Mondal, S. Chowdhury, S. Guria, A clinicopathogenetic study on graves’ orbitopathy in a tertiary care hospital setting in eastern India. ijcmpr ume-6(Issue 01), No.4876–4881 (2020). https://doi.org/10.24327/23956429.ijcmpr202001823. JanuaryAPage

    Article  Google Scholar 

  7. P. Heukels, J.A.C. van Hulst, M. van Nimwegen, C.E. Boorsma, B.N. Melgert, K.L.M. van den Toorn, A.T. Boomars, M.S. Wijsenbeek, H. Hoogsteden, J.H. von der Thüsen, R.W. Hendriks, M. Kool, B. Blink van den, Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis. Respiratory Res. 19, 90 (2018). https://doi.org/10.1186/s12931-018-07988

    Article  CAS  Google Scholar 

  8. P. Darrell, H.G. Richard, Differentiation of circulating monocytes into fibroblast-like cells methods. Mol. Biol. 904, 191–206 (2012). https://doi.org/10.1007/978-1-61779-943-3_16

    Article  CAS  Google Scholar 

  9. C.L. Galligan, E.N. Fish, The role of circulating fibrocytes in inflammation and autoimmunity. J. Leukoc. Biol. ume 93(1), 45–50 (January 2013). https://doi.org/10.1189/jlb.0712365

    Article  CAS  Google Scholar 

  10. E.F. Gillespie, K.I. Papageorgiou, R. Fernando, N. Raychaudhuri, K.P. Cockerham, L.K. Charara, A.C.P. Goncalves, S.X. Zhao, A. Ginter, Y. Lu, T.J. Smith, R.S. Douglas, Increased Expression of TSH Receptor by Fibrocytes in Thyroid-Associated Ophthalmopathy Leads to Chemokine Production. J. Clin. Endocrinol. Metab. 97, E740–E746 (2012). https://doi.org/10.1210/jc.2011-2514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. S. Iyer, R. Bahn, Immunopathogenesis of Graves’ ophthalmopathy: the role of the TSH receptor. Best. Pr. Res Clin. Endocrinol. Metab. 26(3), 281–289 (June 2012). https://doi.org/10.1016/j.beem.2011.10.003

    Article  CAS  Google Scholar 

  12. J. Barrio-Barrio, A.L. Sabater, E. Bonet-Farriol, Á. Velázquez-Villoria, J.C. Galofré. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. Journal of ophthalmology (2015). https://doi.org/10.1155/2015/249125

  13. A. Moeller, S.E. Gilpin, K. Ask, G. Cox, D. Cook, J. Gauldie, J.M. Peter, L. Farkas, J. Dobranowski, C. Boylan, P.M. O’Byrne, R.M. Strieter, M. Kolb, Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med 179, 588–594 (2009). https://doi.org/10.1164/rccm.200810-1534oc. pp

    Article  PubMed  Google Scholar 

  14. T. Sanyal, P. Bhattacharjee, S. Bhattacharjee, Hypomethylation of mitochondrial D-loop and ND6 with increased mitochondrial DNA copy number in the arsenic-exposed population. Toxicology 408, 54–61 (Sep 2018). https://doi.org/10.1016/j.tox.2018.06.012

    Article  CAS  PubMed  Google Scholar 

  15. P. Chinnappa, L. Taguba, R. Arciaga, C. Faiman, A. Siperstein, A.E. Mehta, S.K. Reddy, C. Nasr, M.K. Gupta, Detection of thyrotropin-receptor messenger ribonucleic acid (mrna) and thyroglobulin mrna transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J. Clin. Endocrinol. Metab. 89(8), 3705–3709 (August 2004). https://doi.org/10.1210/jc.2003-031967

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to all the study participants and the members of our research team for their kind support and cooperation. We are thankful to Prof Mitali Chatterjee [Nodal Officer, Multi-Disciplinary Research Unit (MRU) IPGME&R] for her guidance in flowcytometry.

Author contribution

M.B.: Conceptualization, Investigation, Visualization, writing original draft, T.S.: Analysis of RT PCR data, A.K.: Clinical data acquisition from patients, P.B.: Data curation, validation, writing- review and editing, M.D.: Initial Conceptualization, Project Administration, S.C.: Conceptualization, project administration, supervision, data curation, validation, writing- review and editing.

Funding

We are also thankful to Department of Higher Education, Science Technology and Biotechnology (DHESTBT, West Bengal, Sanction No. 298 (Sanc.)/ST/P/S&T/9G-24/2016 dated on 28.03.2018) and Endocrine Society of India (Sanction No. R2017002 dated on 26.08.2017) for their financial support in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Subhankar Chowdhury.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

The study has the approval of institutional ethics committee [Institute of Post Graduate Medical Education and Research and SSKM Hospital, Kolkata, West Bengal, India. (Memo No. Inst/IEC/2016/445)].

Informed consent

Patients gave their informed written consent to participate.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basak, M., Sanyal, T., Kar, A. et al. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves’ Orbitopathy?. Endocrine 75, 447–455 (2022). https://doi.org/10.1007/s12020-021-02865-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02865-0

Keywords

Navigation